Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System
The Gradient Denervation System is a novel technology intended to treat patients with pulmonary hypertension and associated heart failure. Treatment is accomplished by ablating nerves around the pulmonary artery using therapeutic ultrasound energy in a minimally invasive, percutaneous procedure. The straightforward catheter platform was designed specifically for the pulmonary artery anatomy and leverages known interventional techniques. The treatment goal is to down-regulate the sympathetic activity in the pulmonary vascular tree to reduce vascular resistance and decrease pulmonary pressures.
The PreVail-PH2 Early Feasibility Study is enrolling patients with pulmonary hypertension due to left-sided heart disease, classified by the World Health Organization (WHO) as Group 2 Pulmonary Hypertension. As many as two-thirds of heart failure patients around the world have elevated pulmonary vascular resistance, which is shown to lead to an increased risk of mortality and hospitalization. There are no approved drug or device therapies in the United States for this group of pulmonary hypertension patients.
'We are thrilled with this positive feedback from FDA. The granting of Breakthrough Device Designation marks another important milestone for our pulmonary denervation clinical development program,' said Martin Grasse, Chief Executive Officer of Gradient. 'We remain focused on completion of our early feasibility study as a crucial first step toward developing a targeted treatment option with the potential to improve outcomes and quality of life for these underserved patients.'
About Gradient Denervation TechnologiesGradient Denervation Technologies is a Paris-based medical device company developing a minimally invasive, ultrasound-based device for the treatment of pulmonary hypertension. Gradient leverages intellectual property developed at Stanford University. The Gradient Denervation System is for investigational use only and is not approved for commercial use.
For more information, please visit: https://www.gradientdenervation.com.
CONTACT: Media Contact info@gradientdenervation.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
InsuJet Distribution Expands Across France
NuGen Medical Devices Launches French InsuJet(TM) e-Commerce Platform, Delivering Needle-Free Insulin with On-Demand Clinical Support Toronto, Ontario--(Newsfile Corp. - July 7, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, today unveiled — a dedicated French-language information and e-commerce site for InsuJet™, the Company's needle-free insulin-delivery device. Developed with NuGen's exclusive distributor Sol-Millennium France, the platform gives people living with diabetes in France instant access to product details, educational resources, and secure online purchasing. At checkout, patients may opt for nurse-led onboarding that supports them all the way to seamless enrolment in the recurring consumables program — ensuring confident adoption and lasting adherence. A Growing Market Need According to France's National Health Insurance (Assurance Maladie), diabetes remains a critical — and growing — public-health challenge: in 2022, 4.33 million people were living with diabetes — a prevalence of 6.3 percent. The economic impact is escalating just as quickly: reimbursements tied to diabetes jumped from €7.6 billion in 2015 to more than €10 billion in 2022.1 Complications accounts for a significant share of diabetes-related healthcare costs because most of the 92 % of patients who have type 2 diabetes delay insulin start; 80 % of French physicians blame needle anxiety. By eliminating the needle for France's ~4 million type 2 diabetics, InsuJet™ promotes earlier insulin use and delivers substantial savings to the national health system.2 These figures highlight the urgent need for innovative, cost-effective solutions such as InsuJet's needle-free insulin-delivery technology. About InsuJet™ Designed for adults and children (age 6+), InsuJet™ delivers standard U-100 insulin via a precise high-pressure micro-jet through the nozzle that penetrates the skin without needles. Users experience less anxiety, no sharps-disposal burden, and simpler day-to-day diabetes management. Clinical studies demonstrate faster insulin absorption, tighter glycaemic control, and higher patient satisfaction versus traditional needles - advances that directly address France's call for safer, more economical diabetes care. Key Features: Durability — reusable for up to 5,000 injections (≈ 3.5 years at four injections per day) Universally compatible — works with any U-100 insulin in 3 mL cartridges, prefilled insulin pens, or 10 mL vials Needle-free convenience — eliminates sharps containers and related waste CE marked — compliant with European medical-device standards Broad usability — approved for adults and children aged six and over Adoption and Interest from the Clinical Community: The healthcare community has responded enthusiastically to the introduction of InsuJet™. Officially pre-launched at the 2025 Congress of the Société Francophone du Diabète (SFD) this past April, where it was named Innovation of the Year in Insulin Therapy, InsuJet™ attracted significant clinical interest. Numerous hospitals requested demonstrations, leading to two clinical evaluations at the Institut de Diabétologie et Nutrition du Centre (IDNC). These studies aim to support national reimbursement and further validate the clinical and economic benefits of needle-free insulin delivery. About NuGen Medical Devices NuGen develops next-generation needle-free devices for subcutaneous drug delivery. Its flagship InsuJet™ system is approved in 42 countries and is designed to improve the lives of millions of people with diabetes worldwide. About Sol-Millennium Medical Group Sol-Millennium Medical Group is a vertically integrated manufacturer of medical devices. With global operations and a commitment to deliver advanced, patient-centric healthcare technologies, Sol-Millennium Medical partners with healthcare providers to improve outcomes and build a healthier tomorrow for all. Websites: | | / X: @NuGenMD | LinkedIn: NuGenMDInvestor Relations: IR@ For further information, please contact: Liang Lin, Chief Executive Officer+1 (833) 285-2666ir@ Notice Regarding Forward-Looking Information: Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release. This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law. 1 To view the source version of this press release, please visit
Chicago Tribune
3 hours ago
- Chicago Tribune
Illinois-based American Academy of Pediatrics sues Robert F. Kennedy Jr. over vaccine changes
The Illinois-based American Academy of Pediatrics and five other prominent medical groups are suing Robert F. Kennedy Jr., over changes made to COVID-19 vaccine recommendations for children and pregnant women. The lawsuit, filed Monday in U.S. District Court for the District of Massachusetts, alleges that a decision in May to remove COVID-19 vaccines from the federal list of recommended vaccines for healthy children and pregnant women was unlawful and 'endangering the lives of patients.' 'The Directive has put all (American Academy of Pediatrics) members (and, indeed, all other physicians in this country) in the untenable position of telling their patients that the country's top-ranking government health official's advice and recommendations are wrong and that we are right,' according to the lawsuit. 'This erodes trust, which is the foundation of a healthy physician-patient relationship and vital to the success of AAP members' medical practices.' Now, instead of recommending the vaccine for healthy children, the Centers for Disease Control and Prevention says healthy children may receive the vaccine after 'a decision process between the health care provider and the patient or parent/guardian.' The medical groups want the court to bar the federal government from enforcing and publicizing the new recommendations, and they want the court to declare the change unlawful and restore the previous recommendations. The U.S. Department of Health and Human Services, which is also named as a plaintiff in the lawsuit, did not immediately respond to a request for comment Monday afternoon. But in a video posted to X in May announcing the change, Dr. Jay Bhattacharya, director of the National Institutes of Health, said of the change, 'It's common sense, and it's good science.' In that same video, U.S. Food and Drug Administration Commissioner Dr. Marty Makary said, 'There's no evidence healthy kids need it today and most countries have stopped recommending it for children.' Bhattacharya, Makary, the FDA, the National Institutes of Health, the Centers for Disease Control and Prevention and the head of the CDC are also named as defendants in the lawsuit. Other plaintiffs in the case include the American College of Physicians, the American Public Health Association, the Infectious Diseases Society of America, the Massachusetts Public Health Alliance, the Society for Maternal-Fetal Medicine and an unnamed pregnant doctor. The medical groups allege in the lawsuit that the change was against the law partly because Kennedy bypassed the usual process for making changes to the list of recommended vaccines. Normally, a committee called the Advisory Committee for Immunization Practices (ACIP) makes recommendations to the CDC about vaccines. Kennedy has also faced criticism in recent weeks for firing all the members of ACIP and replacing them with others. 'This wasn't just sidelining science,' said Dr. Susan Kressly, president of the Itasca-based American Academy of Pediatrics, in a video posted to the group's website. 'It's an attack on the very foundation of how we protect families and children's health. And the consequences could be dangerous.' Since the change to the COVID-19 vaccine recommendations, pediatricians have had to spend more time talking with distressed parents about the effectiveness of COVID-19 vaccines, according to the lawsuit. The lawsuit describes one pediatrician's struggle, saying: 'The CDC's current emphasis on 'shared decision-making' for the Covid vaccine for children has put a chilling effect on her practice. Shared decision-making implies that the Covid vaccine is optional or suspect, making it harder to hold Covid vaccine clinics, limiting her practice's ability to order vaccines in bulk, and creating reimbursement challenges.' Because of the 'confusion and lack of evidence-based data' supporting the changes, the American Academy of Pediatrics has chosen not to endorse the CDC's current child and adolescent vaccination schedule and is instead endorsing the schedule as it stood before the changes, according to the lawsuit.
Business Journals
5 hours ago
- Business Journals
UH's NSM Career Center is redefining STEM talent pipelines — and Houston industry is taking notice
In an era where the demand for STEM professionals is outpacing supply, Houston-based companies—particularly those in energy, healthcare, technology, and aerospace — are facing a strategic imperative: how to attract, retain, and develop the next generation of scientific and technical talent. Amid this challenge, the University of Houston's College of Natural Sciences & Mathematics (NSM) has introduced a bold solution that is already drawing attention from employers across the region. The NSM Career Center is not just another campus career office. It is a first-of-its-kind, student-driven talent development engine, designed in collaboration with industry leaders and tailored specifically to the evolving needs of candidates. This innovative model is transforming how corporations engage with early-career STEM talent by focusing not only on recruitment, but also on long-term workforce development and brand alignment. A modern pipeline for STEM Talent — rooted in Houston With more than 6,000 undergraduate and graduate students enrolled in its programs—and over 2,000 studying computer science alone, NSM stands out as one of the largest and highest quality STEM talent pools in Texas. The college offers rigorous, industry-relevant training across many areas including: Computer science, cybersecurity, AI and machine learning Data science and analytics, finance, and actuarial science Geology, geophysics, environmental sciences, atmospheric sciences, hydrocarbon exploration R&D, carbon sequestration, chemistry, biology, biochemistry, gene fusion and immunotherapy Physics, medical imaging, superconductivity, nanotechnology and materials science By combining technical rigor with practical skills and professional development, NSM is producing job-ready graduates who are both capable and agile—traits increasingly critical in today's complex, multidisciplinary work environments. expand More than recruitment: A strategic talent partnership Rather than rely solely on traditional career fairs and job boards, the NSM Career Center adopts a consultative, co-creative model designed to deliver meaningful outcomes for employers. Each corporate partner is paired with a dedicated student director, who is a trained undergraduate leader who works in close coordination with NSM's award-winning faculty and staff to deliver customized engagement plans that amplify employer brand visibility and maximize applicant yield. 'Opportunities can be arranged to interact directly with students and faculty to discuss the technical and social skill sets needed for success in the workforce', says Donna Pattison, Ph.D., associate dean of curriculum, instruction, and career development. These partnerships can include custom career events such as employer-hosted Tech Talks, resume reviews, and industry-led 'Escape Room' info sessions, targeted promotional campaigns across student networks and social platforms, resume books filtered by skillset and class year tailored to employer needs. Organizations can offer business challenges allowing companies to present real-world problems to student teams in exchange for fresh, data-driven solutions and have an inside look at potential hires in action. For companies with complex challenges, tight innovation cycles, or a desire to evaluate potential candidates before making a hire, these projects offer a compelling ROI. For employers, this model creates a deeper and more authentic presence on campus. Instead of one-off interactions, companies become embedded within the NSM ecosystem, gaining access not only to top students but also to the unique insights, energy, and creativity that student-led initiatives can offer. Corporate partnership tiers: Flexible, impactful, and scalable Whether you're exploring early engagement or seeking a robust, long-term collaboration, NSM offers flexible partnership tiers designed to meet a range of strategic goals. Benefits include premium career fair booth placement, customized outreach via the HireNSM platform, priority scheduling for events like hack-a-thons, mentorship days, and internship bootcamps, Co-branded marketing, early access to project teams and invitations to talent showcases. Corporate partners are provided strategic advising from the NSM Career Center's leadership to align campus engagement with corporate workforce objectives. These partnerships are not just about immediate hires—they're about building long-term pipelines and embedding your brand into the educational journey of high-caliber STEM talent. expand For companies looking to connect with candidates in real time, the upcoming Natural Sciences and Mathematics + Computer Science Career Fair & Graduate School Expo, Tuesday, Sept. 16, 2025 (1 to 5 p.m.), offers a premier opportunity to meet hundreds of high-achieving students and recent graduates under one roof. 'Employers in energy, tech, healthcare, and beyond are realizing the importance of engaging with STEM students earlier and more meaningfully,' says Dawnelle Prince, director of the NSM Career Center. 'We're not just preparing students for the workforce—we're helping shape it.' STEM Starts Here. Let's Build What's Next —Together. Connect with us to become a corporate partner, let our student directors advise on your campus engagement strategy, and join us for our upcoming career fair by reaching out to HireNSM@ 713-743-6137. The NSM Career Center at the University of Houston is a pioneering force in STEM talent development. As the only student-led career center of its kind in the U.S., its success is driven by strategic employer partnerships and a focus on connecting industry leaders with top-tier STEM talent. Student directors lead thought-provoking dialogue on the challenges of recruiting and retaining early-career professionals while offering actionable, real-world solutions. Through a blend of innovative programming and proven traditional events, the center effectively bridges the gap between students and employers. As a dynamic hub for workforce engagement and student success, the NSM Career Center stands ready to support Houston employers in building strong pipelines of future STEM leaders. Connect with us to meet the NSMCC student directors, attend our upcoming career fair, and add your company to our fall recruitment calendar by reaching out to HireNSM@ 713-743-6137.
